We are thrilled to announce our New Distribution Partnership: from now on, our robotic exoskeleton will be available in Poland thanks to our new official distributor, SKYFI Sp. z o.o.!
Research has shown that rehabilitation with robotic devices, combined with conventional therapy, is more effective than gait training without these devices.
In early April 2024, we collaborated with the Fundación Esclerosis Múltiple Madrid (FEMM) to conduct a clinical trial to validate the ABLE Exoskeleton for people affected by multiple sclerosis (MS).
We are so excited to announce our participation on the Programa d’Accés de la Innovació al Sistema de Salut de Catalunya (PASS), a BIOCAT inniative. To facilitate the access of innovation and technology to the Catalan Health System, BIOCAR in collaboration with AQuAS and CatSalut, has announced the Programa de
ABLE has started taking steps in Madrid at the Centro Europeo de Neurociencias (CEN)
Starting in June 2024 you can find ABLE Exoskeleton in CEFINE Neurología, a neurorehabilitation clinic.
